PHIO PHARMACEUTICALS CORP. Deferred Tax Assets, Operating Loss Carryforwards
PHIO PHARMACEUTICALS CORP. (PHIO) had Deferred Tax Assets, Operating Loss Carryforwards of $1.99 million as of 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-05
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $1.99M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $26.00K.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $774.00K.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $11.81M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $1.99M 10-K · filed 2026-03-05 | |
| 2024-12-31 | $26.00K 10-K · filed 2026-03-05 | |
| 2023-12-31 | $774.00K 10-K · filed 2025-03-31 | |
| 2022-12-31 | $11.81M 10-K · filed 2024-04-01 | |
| 2021-12-31 | $10.15M 10-K · filed 2023-03-22 | |
| 2020-12-31 | $6.36M 10-K · filed 2022-03-22 | $22.31M 10-K · filed 2021-03-25 |
| 2019-12-31 | $19.65M 10-K · filed 2021-03-25 | |
| 2018-12-31 | $16.96M 10-K · filed 2020-03-26 | |
| 2017-12-31 | $14.68M 10-K · filed 2019-03-27 | |
| 2016-12-31 | $17.25M 10-K · filed 2018-03-26 | |
| 2015-12-31 | $13.55M 10-K · filed 2017-03-30 | |
| 2014-12-31 | $9.80M 10-K · filed 2016-03-30 | |
| 2013-12-31 | $6.59M 10-K · filed 2015-03-30 | |
| 2012-12-31 | $3.05M 10-K · filed 2014-03-28 | |
| 2011-12-31 | $986.00K 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |